Company Filing History:
Years Active: 2016
Title: Richard Mears: Innovator in Triterpene Derivatives
Introduction
Richard Mears is a notable inventor based in Oxford, GB. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on triterpene derivatives. His research focuses on developing novel compounds that have the potential to treat serious health conditions.
Latest Patents
Richard Mears holds a patent for "Extended triterpene derivatives." This invention concerns novel pharmaceutically active triterpene derivatives and pharmaceutical compositions containing these compounds. The patent outlines their use as medicaments and describes a method of treatment involving the administration of these compounds. Specifically, the compounds are derivatives of betulinic acid with substitutions at one or more of the C-3, C2-8, and C-19 positions. These novel compounds are particularly useful as antiretroviral agents for the treatment of Human Immunodeficiency Virus (HIV).
Career Highlights
Richard Mears is associated with Myrexis, Inc., where he has been instrumental in advancing pharmaceutical research. His work has contributed to the development of new therapeutic options for patients suffering from viral infections.
Collaborations
Richard has collaborated with notable colleagues, including Theodore John Nitz and Christian Montalbetti. These partnerships have enhanced the research and development efforts within his field.
Conclusion
Richard Mears is a distinguished inventor whose work on triterpene derivatives has the potential to impact the treatment of HIV significantly. His contributions to pharmaceutical innovation are noteworthy and reflect his commitment to advancing medical science.